Compare CALX & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CALX | LIVN |
|---|---|---|
| Founded | 1999 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.5B |
| IPO Year | 2009 | 2015 |
| Metric | CALX | LIVN |
|---|---|---|
| Price | $53.20 | $70.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $74.75 | $70.25 |
| AVG Volume (30 Days) | ★ 1.3M | 796.7K |
| Earning Date | 04-29-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.78 | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $510,367,000.00 | N/A |
| Revenue This Year | $16.40 | $8.14 |
| Revenue Next Year | $13.75 | $6.53 |
| P/E Ratio | $198.21 | ★ N/A |
| Revenue Growth | ★ 11.24 | N/A |
| 52 Week Low | $28.61 | $32.48 |
| 52 Week High | $71.22 | $71.58 |
| Indicator | CALX | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 51.13 | 67.09 |
| Support Level | $51.66 | $61.50 |
| Resistance Level | $56.17 | N/A |
| Average True Range (ATR) | 2.62 | 2.33 |
| MACD | 0.00 | 0.30 |
| Stochastic Oscillator | 47.83 | 86.97 |
Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.